LLY vs LH
By Alex · Tickerpine
Eli Lilly and Company vs Labcorp Holdings Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | LH |
|---|---|---|
| Price | $1,184.78 | $309.57 |
| Market cap | $1.06T | $25.11B |
| P/E ratio | 39.7 | 25.6 |
| ROE | 102.29% | 11.73% |
| Profit margin | 33.53% | 6.99% |
| Revenue growth | 47.70% | 5.80% |
| Dividend yield | 0.58% | 0.93% |
| Beta | 0.50 | 0.85 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs LH in plain English
- LLY is the bigger company — about 42.1× the market cap of LH.
- LH is cheaper on earnings (P/E 25.6 vs 39.7).
- LLY earns a higher return on equity (102% vs 12%).
- LLY is growing revenue faster (48% vs 6%).
- LH has the higher dividend yield (0.93% vs 0.58%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
LH return calculator
See what $1,000 in Labcorp Holdings Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.